scholarly article | Q13442814 |
P50 | author | Gil Omenn | Q5560581 |
Matan Hofree | Q87906411 | ||
Massimo Cristofanilli | Q91695610 | ||
Trey Ideker | Q16335202 | ||
Michael P. Snyder | Q28924918 | ||
Susan Fanayan | Q38639422 | ||
P2093 | author name string | Zhaomei Mu | |
Ronald C Beavis | |||
William S Hancock | |||
Young-Ki Paik | |||
Shiaw-Lin Wu | |||
Seul-Ki Jeong | |||
James M Reuben | |||
Hogune Im | |||
Emma Yue Zhang | |||
Anna Fan Zhang | |||
Fredika Robertson | |||
P2860 | cites work | Mapping and quantifying mammalian transcriptomes by RNA-Seq | Q22122035 |
Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA) | Q24294659 | ||
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4 | Q24318320 | ||
A census of human cancer genes | Q24647081 | ||
Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution | Q24676904 | ||
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation | Q24678674 | ||
Comparing protein abundance and mRNA expression levels on a genomic scale | Q24682985 | ||
Targeting RAS signalling pathways in cancer therapy | Q28201363 | ||
Effects of methylation on expression of TMS1/ASC in human breast cancer cells | Q28207669 | ||
An unconventional pathway for reduction of CO2 to methane in CO-grown Methanosarcina acetivorans revealed by proteomics | Q28273832 | ||
Personal omics profiling reveals dynamic molecular and medical phenotypes | Q29614800 | ||
CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer. | Q30010476 | ||
Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions | Q30165423 | ||
An approach to the proteomic analysis of a breast cancer cell line (SKBR-3). | Q30780232 | ||
Significance analysis of spectral count data in label-free shotgun proteomics | Q31164168 | ||
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer | Q33303529 | ||
Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients | Q33390513 | ||
BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines | Q33523959 | ||
The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy | Q33592958 | ||
The development of an integrated platform to identify breast cancer glycoproteome changes in human serum. | Q34080000 | ||
The EGF receptor family as targets for cancer therapy | Q34293543 | ||
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | Q34314489 | ||
Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes | Q34354173 | ||
Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration | Q34791886 | ||
Identifying and validating causal genetic alterations in human breast cancer | Q35130673 | ||
A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome | Q35140579 | ||
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer | Q35759154 | ||
Epigenetic silencing of 14-3-3sigma in cancer | Q36477686 | ||
Molecular cytogenetic analysis of 11 new breast cancer cell lines | Q36619975 | ||
Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells | Q36626059 | ||
Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line | Q36832476 | ||
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells | Q37131339 | ||
Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. | Q37131357 | ||
Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells | Q37383705 | ||
The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer | Q37630052 | ||
Dual HER2-targeted approaches in HER2-positive breast cancer | Q37940203 | ||
Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival | Q38426352 | ||
Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients | Q38517823 | ||
Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. | Q39820488 | ||
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition | Q39844747 | ||
A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers | Q40003301 | ||
Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility | Q40156318 | ||
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. | Q40303976 | ||
Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. | Q40475728 | ||
Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines | Q40612612 | ||
The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells | Q41575100 | ||
The role of S100 genes in breast cancer progression | Q42481244 | ||
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients | Q42519924 | ||
In Silico Protein Interaction Analysis Using the Global Proteome Machine Database | Q42681450 | ||
Mammalian housekeeping genes evolve more slowly than tissue-specific genes | Q48221814 | ||
Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors | Q53375722 | ||
Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines. | Q55135279 | ||
Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival | Q57713449 | ||
Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells | Q72069277 | ||
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays | Q77220709 | ||
Uniting ENCODE with genome-wide proteomics | Q85397381 | ||
Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes | Q87377000 | ||
P433 | issue | 6 | |
P921 | main subject | Erb-b2 receptor tyrosine kinase 2 | Q415271 |
RNA sequencing | Q2542347 | ||
inflammatory breast cancer | Q5922406 | ||
P304 | page(s) | 2805-2817 | |
P577 | publication date | 2013-05-22 | |
P1433 | published in | Journal of Proteome Research | Q3186939 |
P1476 | title | Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer | |
P478 | volume | 12 |
Q34010823 | A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines |
Q40738932 | BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder |
Q35867159 | Branched-Chain Aminotransferases Control TORC1 Signaling in Saccharomyces cerevisiae |
Q34080008 | Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform |
Q37619141 | Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes |
Q38938061 | Identification of frequent somatic mutations in inflammatory breast cancer |
Q54281598 | Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study. |
Q38402575 | Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues |
Q53462538 | Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? |
Q36703120 | MI-PVT: A Tool for Visualizing the Chromosome-Centric Human Proteome |
Q34664059 | Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice. |
Q30834972 | Novel bioinformatics method for identification of genome-wide non-canonical spliced regions using RNA-Seq data. |
Q36992268 | Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins |
Q34556822 | Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide |
Q27014674 | Targeting SH2 domains in breast cancer |
Q48597281 | The chromosome-centric human proteome project at FEBS Congress |
Q37215538 | The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease |
Q38296676 | The role of CT10 regulation of kinase-like in cancer |
Q92942425 | The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma |
Search more.